WIIK PHARMA ApS — Credit Rating and Financial Key Figures
CVR number: 36481315
Bogøvej 15, 8382 Hinnerup
tel: 31367080
www.wiikpharma.dk
Income statement (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | 2 536.53 | 3 403.41 | 3 172.30 | 4 087.84 | 6 666.20 |
| Employee benefit expenses | -1 413.76 | -1 627.46 | -1 829.69 | -2 708.93 | -2 940.07 |
| EBIT | 1 122.77 | 1 775.96 | 1 342.60 | 1 378.90 | 3 726.13 |
| Other financial income | 4.77 | 24.79 | 0.13 | 22.81 | 97.33 |
| Other financial expenses | -58.51 | -58.82 | -59.47 | -71.07 | - 230.86 |
| Pre-tax profit | 1 069.03 | 1 741.93 | 1 283.27 | 1 330.64 | 3 592.59 |
| Income taxes | - 239.11 | - 387.54 | - 285.05 | - 299.54 | - 796.47 |
| Net earnings | 829.92 | 1 354.39 | 998.21 | 1 031.11 | 2 796.13 |
Assets (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Tangible assets total | |||||
| Other receivables | 21.00 | 30.73 | 30.73 | 21.60 | 23.60 |
| Investments total | 21.00 | 30.73 | 30.73 | 21.60 | 23.60 |
| Long term receivables total | |||||
| Inventories total | |||||
| Current trade debtors | 325.33 | 2 026.56 | 1 301.41 | 1 636.30 | 3 813.82 |
| Current amounts owed by group member comp. | 5.80 | 9.08 | 3.47 | 3.61 | 1 344.11 |
| Current other receivables | 25.00 | 45.37 | 6.75 | ||
| Short term receivables total | 356.13 | 2 081.02 | 1 304.88 | 1 639.91 | 5 164.67 |
| Cash and bank deposits | 2 589.48 | 3 112.84 | 3 161.71 | 3 201.09 | 4 146.23 |
| Cash and cash equivalents | 2 589.48 | 3 112.84 | 3 161.71 | 3 201.09 | 4 146.23 |
| Balance sheet total (assets) | 2 966.61 | 5 224.59 | 4 497.33 | 4 862.60 | 9 334.50 |
Equity and liabilities (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Share capital | 50.00 | 50.00 | 50.00 | 50.00 | 50.00 |
| Shares repurchased | 825.00 | 1 350.00 | 995.00 | 1 000.00 | 2 596.00 |
| Retained earnings | - 818.00 | -1 338.08 | - 978.69 | - 980.48 | -2 545.37 |
| Profit of the financial year | 829.92 | 1 354.39 | 998.21 | 1 031.11 | 2 796.13 |
| Shareholders equity total | 886.92 | 1 416.31 | 1 064.52 | 1 100.63 | 2 896.76 |
| Non-current liabilities total | |||||
| Current loans from credit institutions | 34.61 | ||||
| Advances received | 229.50 | 439.12 | 59.49 | ||
| Current trade creditors | 842.48 | 1 526.05 | 1 715.41 | 1 988.03 | 3 810.32 |
| Current owed to participating | 1.30 | 0.69 | |||
| Current owed to group member | 251.00 | 188.29 | |||
| Short-term deferred tax liabilities | 226.56 | 339.00 | 285.05 | 299.54 | 796.47 |
| Other non-interest bearing current liabilities | 779.84 | 1 503.41 | 1 121.85 | 1 251.50 | 1 830.96 |
| Current liabilities total | 2 079.69 | 3 808.29 | 3 432.81 | 3 761.97 | 6 437.74 |
| Balance sheet total (liabilities) | 2 966.61 | 5 224.59 | 4 497.33 | 4 862.60 | 9 334.50 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.